Table 2.
Best objective response.
| Total | ASPS | Non-ASPS | SS | UPS | |
|---|---|---|---|---|---|
| N | 30 | 12 | 18 | 7 | 5 |
| PD | 4 (13.33) | — | 4 (22.22) | 3 (42.86) | 1 (20.00) |
| iUPD | 3 (10.00) | — | 3 (16.67) | — | 1 (20.00) |
| SD | 12 (40.00) | 3 (25.00) | 9 (50.00) | 4 (57.14) | 3 (60.00) |
| PR | 10 (33.33) | 8 (66.67) | 2 (11.11) | — | — |
| CR | 1 (3.33) | 1 (8.33) | — | — | — |
| ORR | 36.67 | 75.00 | 11.11 | 0 | 0 |
| 95% CI | 19.93–56.14 | 42.81–94.51 | 1.38–34.71 | — | — |
| DCR | 76.67 | 100 | 61.11 | 57.14 | 60.00 |
| 95% CI | 57.72–90.07 | 73.54–100 | 35.75–82.70 | 18.41–90.10 | 14.66–94.73 |
Abbreviations: SS, synovial sarcoma; iUPD, unconfirmed immune PD.